Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Harvard Business School
Mallinckrodt
Johnson and Johnson
Colorcon
Dow
Novartis
Teva
Covington

Generated: August 19, 2017

DrugPatentWatch Database Preview

TOBREX Drug Profile

« Back to Dashboard

Which patents cover Tobrex, and when can generic versions of Tobrex launch?

Tobrex is a drug marketed by Sandoz Inc and Novartis Pharms Corp and is included in three NDAs.

The generic ingredient in TOBREX is tobramycin. There are eighteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tobramycin profile page.

Summary for Tradename: TOBREX

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list67
Clinical Trials: see list2
Patent Applications: see list6,686
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOBREX at DailyMed

Pharmacology for Tradename: TOBREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
TOBREX
tobramycin
SOLUTION/DROPS;OPHTHALMIC062535-001Dec 13, 1984ATRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBREX
tobramycin
SOLUTION/DROPS;OPHTHALMIC050541-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBREX
tobramycin
OINTMENT;OPHTHALMIC050555-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Dow
Covington
Johnson and Johnson
Novartis
Fish and Richardson
Medtronic
Baxter
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot